Posts From King World News

GSK hopes big clinical trial can breath new life into lung drug

By Ben Hirschler LONDON (Reuters) – GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result. Data from the so-called SUMMIT study, designed to show GSK’s Breo can prolong lives of patients with chronic lung disease, are expected as early as next month, nine years after a similar study with GSK’s older drug Advair

U.S. court revives $45 million patent verdict against Limelight

By Andrew Chung NEW YORK (Reuters) – Limelight Networks’ is responsible for infringing rival Akamai Technologies Inc’s patent for managing Web images and video, a U.S. appeals court ruled on Thursday, reviving a $45 million verdict against the company. The U.S. Court of Appeals for the Federal Circuit in the District of Columbia said Limelight’s control over its customers’ use of its services to deliver media content over the Internet

Humans may face malnutrition if birds and bees disappear

By Lisa Rapaport (Reuters Health) – If all the birds, bugs, bees and other creatures that pollinate our food crops were to disappear from the planet, humans could face a sharp increase in malnutrition, disease and death in many parts of the world, scientists estimate. Researchers analyzed supplies of 224 types of food in 156 countries, quantified the vitamins and nutrients in foods dependent on animal pollinators, and then calculated

Shire seen having wiggle room on price in $30 billion Baxalta battle

Baxalta wants Shire to improve on its $30 billion bid significantly before it will engage in talks, while its Dublin-based rival could sweeten its offer if it gets to see the U.S. biotech company’s books, according to sources on both sides. Bolstered by the backing of its shareholders, Baxalta’s management is digging in by scorning Shire’s initial approach as woefully inadequate for a newly listed company which expects its shares